Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic Impact
Abstract
1. Introduction
2. Materials and Methods
3. Results
3.1. Microbiome in Male Patients
3.2. Microbiome in Female Patients
3.3. The Effects of Bladder Cancer on Urinary Microbiome
3.4. The Impact of TURBT on Urinary Microbiome
3.5. The Impact of BCG Chemotherapy on Urinary Microbiome
3.6. The Impact of Toxic Substances on Urinary Microbiome
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
Abbreviations
NMIBC | Non-muscle invasive bladder cancer |
EAU | European Association of Urology |
TURBT | Trans-urethral resection of bladder tumor |
UB | Urinary microbiome |
TMB | Tumor mutational burden |
BPH | Benign prostatic hyperplasia |
LUTS | Lower urinary tract symptoms |
STD | Sexually transmitted disorders |
IPSS | International Prostate Symptom Score |
NGS | Next-generation sequencing |
BC | Bladder cancer |
HBD | Human beta-defensins |
UTI | Urinary tract infections |
RC | Radical cystectomy |
AUC | Area under the curve |
FM | First-morning urine |
HPV | Human Papillomavirus |
IVT | Intravesical therapy |
iAs | Inorganic arsenic |
References
- Zhang, Y.; Rumgay, H.; Li, M.; Yu, H.; Pan, H.; Ni, J. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J. Glob. Health 2023, 13, 04109. [Google Scholar] [CrossRef]
- GLOBOCAN 2020: Bladder Cancer 10th Most Commonly Diagnosed Worldwide. World Bladder Cancer Patient Coalition. Available online: https://worldbladdercancer.org/news_events/globocan-2020-bladder-cancer-10th-most-commonly-diagnosed-worldwide/ (accessed on 16 May 2025).
- Microbiome Profiling in Bladder Cancer Patients Using the First-Morning Urine Sample—European Urology Open Science. Available online: https://www.eu-openscience.europeanurology.com/article/S2666-1683(23)02314-5/fulltext (accessed on 16 May 2025).
- Neugent, M.L.; Hulyalkar, N.V.; Nguyen, V.H.; Zimmern, P.E.; De Nisco, N.J. Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection. MBio 2020, 11, 10–1128. Available online: https://journals.asm.org/doi/10.1128/mBio.00218-20 (accessed on 20 July 2025). [CrossRef]
- Multhoff, G.; Molls, M.; Radons, J. Chronic Inflammation in Cancer Development. Front. Immunol. 2012, 2, 98. [Google Scholar] [CrossRef]
- Chorbińska, J.; Krajewski, W.; Nowak, Ł.; Bardowska, K.; Żebrowska-Różańska, P.; Łaczmański, Ł.; Pacyga-Prus, K.; Górska, S.; Małkiewicz, B.; Szydełko, T. Is the Urinary and Gut Microbiome Associated With Bladder Cancer? Clin. Med. Insights Oncol. 2023, 17, 11795549231206796. [Google Scholar] [CrossRef]
- Siddiqui, R.; Boghossian, A.; Alharbi, A.M.; Alfahemi, H.; Khan, N.A. The Pivotal Role of the Gut Microbiome in Colorectal Cancer. Biology 2022, 11, 1642. [Google Scholar] [CrossRef] [PubMed]
- Singh, N.; Baby, D.; Rajguru, J.; Patil, P.; Thakkannavar, S.; Pujari, V. Inflammation and cancer. Ann. Afr. Med. 2019, 18, 121. [Google Scholar] [CrossRef] [PubMed]
- Wu, C.; Wei, X.; Huang, Z.; Zheng, Z.; Zhang, W.; Chen, J.; Hong, H.; Li, W. Urinary microbiome dysbiosis is associated with an inflammatory environment and perturbed fatty acids metabolism in the pathogenesis of bladder cancer. J. Transl. Med. 2024, 22, 628. Available online: https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05446-7 (accessed on 20 July 2025). [CrossRef]
- Dyrskjøt, L.; Hansel, D.E.; Efstathiou, J.A.; Knowles, M.A.; Galsky, M.D.; Teoh, J.; Theodorescu, D. Bladder cancer. Nat. Rev. Dis. Primers 2023, 9, 58. [Google Scholar] [CrossRef]
- Hussein, A.A.; Elsayed, A.S.; Durrani, M.; Jing, Z.; Iqbal, U.; Gomez, E.C.; Singh, P.K.; Liu, S.; Smith, G.; Tang, L.; et al. Investigating the association between the urinary microbiome and bladder cancer: An exploratory study. Urol. Oncol. 2021, 39, 370.e9–370.e19. [Google Scholar] [CrossRef]
- Kenneally, C.; Murphy, C.P.; Sleator, R.D.; Culligan, E.P. The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections. Microbiol. Res. 2022, 259, 127010. [Google Scholar] [CrossRef]
- Pederzoli, F.; Ferrarese, R.; Amato, V.; Locatelli, I.; Alchera, E.; Lucianò, R.; Nebuloni, M.; Briganti, A.; Gallina, A.; Colombo, R.; et al. Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients. Eur. Urol. Oncol. 2020, 3, 784–788. [Google Scholar] [CrossRef]
- Ma, Y.; Feng, X.-F.; Yang, W.-X.; You, C.-G. Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis. Biomed Res. Int. 2019, 2019, 1093815. [Google Scholar] [CrossRef]
- Bersanelli, M.; Santoni, M.; Ticinesi, A.; Buti, S. The Urinary Microbiome and Anticancer Immunotherapy: The Potentially Hidden Role of Unculturable Microbes. Target. Oncol. 2019, 14, 247–252. [Google Scholar] [CrossRef]
- Nelson, D.E.; Pol, B.V.D.; Dong, Q.; Revanna, K.V.; Fan, B.; Easwaran, S.; Sodergren, E.; Weinstock, G.M.; Diao, L.; Fortenberry, J.D. Characteristic Male Urine Microbiomes Associate with Asymptomatic Sexually Transmitted Infection. PLoS ONE 2010, 5, e14116. [Google Scholar] [CrossRef]
- Roth, R.S.; Liden, M.; Huttner, A. The urobiome in men and women: A clinical review. Clin. Microbiol. Infect. 2023, 29, 1242–1248. [Google Scholar] [CrossRef]
- Bajic, P.; Van Kuiken, M.E.; Burge, B.K.; Kirshenbaum, E.J.; Joyce, C.J.; Wolfe, A.J.; Branch, J.D.; Bresler, L.; Farooq, A.V. Male Bladder Microbiome Relates to Lower Urinary Tract Symptoms. Eur. Urol. Focus. 2020, 6, 376–382. [Google Scholar] [CrossRef]
- Kim, M.S.; Jung, S.I. The Urinary Tract Microbiome in Male Genitourinary Diseases: Focusing on Benign Prostate Hyperplasia and Lower Urinary Tract Symptoms. Int. Neurourol. J. 2021, 25, 3–11. [Google Scholar] [CrossRef]
- Wolfe, A.J.; Toh, E.; Shibata, N.; Rong, R.; Kenton, K.; FitzGerald, M.; Mueller, E.R.; Schreckenberger, P.; Dong, Q.; Nelson, D.E.; et al. Evidence of Uncultivated Bacteria in the Adult Female Bladder. J. Clin. Microbiol. 2012, 50, 1376–1383. [Google Scholar] [CrossRef]
- Price, T.K.; Wolff, B.; Halverson, T.; Limeira, R.; Brubaker, L.; Dong, Q.; Mueller, E.R.; Wolfe, A.J. Temporal Dynamics of the Adult Female Lower Urinary Tract Microbiota. MBio 2020, 11, 10–1128. [Google Scholar] [CrossRef]
- Thomas-White, K.; Forster, S.C.; Kumar, N.; Van Kuiken, M.; Putonti, C.; Stares, M.D.; Hilt, E.E.; Price, T.K.; Wolfe, A.J.; Lawley, T.D. Culturing of female bladder bacteria reveals an interconnected urogenital microbiota. Nat. Commun. 2018, 9, 1557. [Google Scholar] [CrossRef]
- Bi, H.; Tian, Y.; Song, C.; Li, J.; Liu, T.; Chen, Z.; Chen, C.; Huang, Y.; Zhang, Y. Urinary microbiota—A potential biomarker and therapeutic target for bladder cancer. J. Med. Microbiol. 2019, 68, 1471–1478. [Google Scholar] [CrossRef]
- Hrbáček, J.; Tláskal, V.; Čermák, P.; Hanáček, V.; Zachoval, R. Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition. Urol. Oncol. 2023, 41, e15–e107. [Google Scholar] [CrossRef]
- Oresta, B.; Braga, D.; Lazzeri, M.; Frego, N.; Saita, A.; Faccani, C.; Fasulo, V.; Colombo, P.; Guazzoni, G.; Hurle, R.; et al. The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage. J. Urol. 2021, 205, 86–93. [Google Scholar] [CrossRef]
- Bukavina, L.; Isali, I.; Ginwala, R.; Sindhani, M.; Calaway, A.; Magee, D.; Miron, B.; Correa, A.; Kutikov, A.; Zibelman, M.; et al. Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients. Eur. Urol. Oncol. 2023, 6, 190–203. [Google Scholar] [CrossRef] [PubMed]
- Parra-Grande, M.; Oré-Arce, M.; Martínez-Priego, L.; D’Auria, G.; Rosselló-Mora, R.; Lillo, M.; Sempere, A.; Lumbreras, B.; Sánchez-Hellín, V. Profiling the Bladder Microbiota in Patients With Bladder Cancer. Front. Microbiol. 2021, 12, 718776. [Google Scholar] [CrossRef]
- Mansour, B.; Monyók, Á.; Gajdács, M.; Stercz, B.; Makra, N.; Pénzes, K.; Vadnay, I.; Szabó, D.; Ostorházi, E. Bladder Tissue Microbiome Composition in Patients of Bladder Cancer or Benign Prostatic Hyperplasia and Related Human Beta Defensin Levels. Biomedicines 2022, 10, 1758. [Google Scholar] [CrossRef]
- Sun, J.-X.; Xia, Q.-D.; Zhong, X.-Y.; Liu, Z.; Wang, S.-G. The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M. Front. Cell. Infect. Microbiol. 2023, 13, 1182322. [Google Scholar] [CrossRef]
- Zhang, Y.; Wang, W.; Zhou, H.; Cui, Y. Urinary Eubacterium sp. CAG: 581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway. Cancers 2023, 15, 809. [Google Scholar] [CrossRef]
- Mai, G.; Chen, L.; Li, R.; Liu, Q.; Zhang, H.; Ma, Y. Common Core Bacterial Biomarkers of Bladder Cancer Based on Multiple Datasets. Biomed. Res. Int. 2019, 2019, 4824909. [Google Scholar] [CrossRef]
- Chen, C.; Huang, Z.; Huang, P.; Li, K.; Zeng, J.; Wen, Y.; Li, B.; Zhao, J.; Wu, P. Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer. BMC Microbiol. 2022, 22, 7. [Google Scholar] [CrossRef]
- Hourigan, S.K.; Zhu, W.; SWWong, W.; Clemency, N.C.; Provenzano, M.; Vilboux, T.; Niederhuber, J.E.; Deeken, J.; Chung, S.; McDaniel-Wiley, K.; et al. Studying the urine microbiome in superficial bladder cancer: Samples obtained by midstream voiding versus cystoscopy. BMC Urol. 2020, 20, 5. [Google Scholar] [CrossRef]
- Zeng, J.; Zhang, G.; Chen, C.; Li, K.; Wen, Y.; Zhao, J.; Wu, P. Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study. Front. Cell. Infect. Microbiol. 2020, 10, 555508. [Google Scholar] [CrossRef]
- Mansour, B.; Monyók, Á.; Makra, N.; Gajdács, M.; Vadnay, I.; Ligeti, B.; Juhász, J.; Szabó, D.; Ostorházi, E. Bladder cancer-related microbiota: Examining differences in urine and tissue samples. Sci. Rep. 2020, 10, 11042. [Google Scholar] [CrossRef]
- Liu, F.; Liu, A.; Lu, X.; Zhang, Z.; Xue, Y.; Xu, J.; Zeng, S.; Xiong, Q.; Tan, H.; He, X.; et al. Dysbiosis signatures of the microbial profile in tissue from bladder cancer. Cancer Med. 2019, 8, 6904–6914. [Google Scholar] [CrossRef] [PubMed]
- Ślusarczyk, A.; Ismail, H.; Zapała, Ł.; Piecha, T.; Zapała, P.; Radziszewski, P. Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study. Ann. Surg. Oncol. 2024, 31, 4773–4786. [Google Scholar] [CrossRef] [PubMed]
- Nardelli, C.; Aveta, A.; Pandolfo, S.D.; Tripodi, L.; Russo, F.; Imbimbo, C.; Castaldo, G.; Pastore, L. Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample. Eur. Urol. Open. Sci. 2024, 59, 18–26. [Google Scholar] [CrossRef]
- Hrbáček, J.; Hanáček, V.; Kadlečková, D.; Cirbusová, A.; Čermák, P.; Tachezy, R.; Zachoval, R.; Saláková, M. Urinary shedding of common DNA viruses and their possible association with bladder cancer: A qPCR-based study. Neoplasma 2023, 70, 311–318. [Google Scholar] [CrossRef] [PubMed]
- James, C.; Gomez, K.; Desai, S.; Patel, H.D.; Rac, G.; Doshi, C.P.; Dornbier, R.; Bajic, P.; Halverson, T.; Gupta, G.N.; et al. Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer. Front. Cell. Infect. Microbiol. 2023, 13, 1125809. [Google Scholar] [CrossRef]
- Ma, W.; Zhang, W.; Shen, L.; Liu, J.; Yang, F.; Maskey, N.; Wang, H.; Zhang, J.; Yan, Y.; Yao, X. Can Smoking Cause Differences in Urine Microbiome in Male Patients With Bladder Cancer? A Retrospective Study. Front. Oncol. 2021, 11, 677605. [Google Scholar] [CrossRef]
- Moynihan, M.; Sullivan, T.; Provenzano, K.; Rieger-Christ, K. Urinary Microbiome Evaluation in Patients Presenting with Hematuria with a Focus on Exposure to Tobacco Smoke. Res. Rep. Urol. 2019, 11, 359–367. [Google Scholar] [CrossRef]
- Chen, X.; Cheng, Y.; Tian, X.; Li, J.; Ying, X.; Zhao, Q.; Wang, M.; Liu, Y.; Qiu, Y.; Yan, X.; et al. Urinary microbiota and metabolic signatures associated with inorganic arsenic-induced early bladder lesions. Ecotoxicol. Environ. Saf. 2023, 259, 115010. [Google Scholar] [CrossRef]
- Chiu, K.; Warner, G.; Nowak, R.A.; Flaws, J.A.; Mei, W. The Impact of Environmental Chemicals on the Gut Microbiome. Toxicol. Sci. 2020, 176, 253–284. [Google Scholar] [CrossRef]
- He, C.; Li, B.; Huang, L.; Teng, C.; Bao, Y.; Ren, M.; Shan, Y. Gut microbial composition changes in bladder cancer patients: A case-control study in Harbin, China. Asia Pac. J. Clin. Nutr. 2020, 29, 395–403. [Google Scholar] [CrossRef] [PubMed]
- Heidar, N.A.; Bhat, T.A.; Shabir, U.; Hussein, A.A. The Urinary Microbiome and Bladder Cancer. Life 2023, 13, 812. [Google Scholar] [CrossRef] [PubMed]
- Ciernikova, S.; Sevcikova, A.; Stevurkova, V.; Mego, M. Tumor microbiome—An integral part of the tumor microenvironment. Front. Oncol. 2022, 12, 1063100. Available online: https://www.frontiersin.org/articles/10.3389/fonc.2022.1063100 (accessed on 22 July 2025). [CrossRef] [PubMed]
- Zhang, W.; Yang, F.; Mao, S.; Wang, R.; Chen, H.; Ran, Y.; Liu, S.; Wu, P.; Yan, Y.; Li, W.; et al. Bladder cancer-associated microbiota: Recent advances and future perspectives. Heliyon 2023, 9, e13012. [Google Scholar] [CrossRef]
- Vendrell, J.A.; Cabello-Aguilar, S.; Senal, R.; Heckendorn, E.; Henry, S.; Godreuil, S.; Solassol, J. Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer. Int. J. Mol. Sci. 2024, 25, 10159. [Google Scholar] [CrossRef]
- Horwitz, D.; McCue, T.; Mapes, A.C.; Ajami, N.J.; Petrosino, J.F.; Ramig, R.F.; Trautner, B.W. Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference. J. Infect. 2015, 71, 358–367. [Google Scholar] [CrossRef]
- Ivleva, E.A.; Grivennikov, S.I. Microbiota-driven mechanisms at different stages of cancer development. Neoplasia 2022, 32, 100829. [Google Scholar] [CrossRef]
- Ammitzbøll, N.; Bau, B.P.J.; Bundgaard-Nielsen, C.; Villadsen, A.B.; Jensen, A.-M.; Leutscher, P.D.C.; Glavind, K.; Hagstrøm, S.; Arenholt, L.T.S.; Sørensen, S. Pre- and postmenopausal women have different core urinary microbiota. Sci. Rep. 2021, 11, 2212. Available online: https://www.nature.com/articles/s41598-021-81790-8 (accessed on 22 July 2025).
- Chee, W.J.Y.; Chew, S.Y.; Than, L.T.L. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb. Cell. Fact. 2020, 19, 203. Available online: https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-020-01464-4 (accessed on 22 July 2025). [CrossRef]
- Lloyd, L. The bladder tumour microbiome and BCG response. Nat. Rev. Urol. 2024, 21, 389. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gherasim, R.-D.; Chibelean, C.; Porav-Hodade, D.; Todea-Moga, C.; Tătaru, S.-O.; Reman, T.-L.; Vida, A.-O.; Ghirca, M.-V.; Ferro, M.; Martha, O.K.I. Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic Impact. Medicina 2025, 61, 1401. https://doi.org/10.3390/medicina61081401
Gherasim R-D, Chibelean C, Porav-Hodade D, Todea-Moga C, Tătaru S-O, Reman T-L, Vida A-O, Ghirca M-V, Ferro M, Martha OKI. Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic Impact. Medicina. 2025; 61(8):1401. https://doi.org/10.3390/medicina61081401
Chicago/Turabian StyleGherasim, Raul-Dumitru, Călin Chibelean, Daniel Porav-Hodade, Ciprian Todea-Moga, Sabin-Octavian Tătaru, Tibor-Lorand Reman, Arpad-Oliver Vida, Maria-Veronica Ghirca, Matteo Ferro, and Orsolya Katalyn Ilona Martha. 2025. "Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic Impact" Medicina 61, no. 8: 1401. https://doi.org/10.3390/medicina61081401
APA StyleGherasim, R.-D., Chibelean, C., Porav-Hodade, D., Todea-Moga, C., Tătaru, S.-O., Reman, T.-L., Vida, A.-O., Ghirca, M.-V., Ferro, M., & Martha, O. K. I. (2025). Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic Impact. Medicina, 61(8), 1401. https://doi.org/10.3390/medicina61081401